Table of Contents

• CVM Advisory Committee Reviews Microbial Safety of Pending Veterinary Antimicrobial [ARCHIVED]
• FDA Brings Residue-Avoidance Message to Livestock Producers [ARCHIVED]
  by Diana Monaco, Public Affairs Specialist, and Beverly Kent, Assistant to the Director, FDA New York District Office
• CVM Approves First 4-Way Combination Drug [ARCHIVED]
• CVM Produces Animation Showing How Bacteria Become Resistant [ARCHIVED]
• How CVM Uses Adverse Drug Experience Reports System [ARCHIVED]
• Ask CVM - September/October 2004 [ARCHIVED]
• Regulatory Activities - September/October 2004 [ARCHIVED]
• CVM Releases NARMS Retail Meat Survey Results [ARCHIVED]
• Buying Unapproved Veterinary Drugs From Abroad Can Expose Pets to Unnecessary Risks [ARCHIVED]
• Approvals for July and August 2004 [ARCHIVED]
• CVM has published in the Federal Register notice of the approval of these Supplemental New Animal Drug Approvals [ARCHIVED]
• CVM has published in the Federal Register notice of the approval of these Abbreviated New Animal Drug Applications (ANADA) [ARCHIVED]